Logo image of BAC

BANK OF AMERICA CORP (BAC) Stock Fundamental Analysis

NYSE:BAC - New York Stock Exchange, Inc. - US0605051046 - Common Stock - Currency: USD

46.67  -0.73 (-1.54%)

After market: 46.65 -0.02 (-0.04%)

Fundamental Rating

3

Taking everything into account, BAC scores 3 out of 10 in our fundamental rating. BAC was compared to 404 industry peers in the Banks industry. BAC may be in some trouble as it scores bad on both profitability and health. BAC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BAC had positive earnings in the past year.
In the past year BAC has reported a negative cash flow from operations.
Each year in the past 5 years BAC has been profitable.
In multiple years BAC reported negative operating cash flow during the last 5 years.
BAC Yearly Net Income VS EBIT VS OCF VS FCFBAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.66%, BAC is doing worse than 60.80% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.40%, BAC is in line with its industry, outperforming 43.97% of the companies in the same industry.
Industry RankSector Rank
ROA 0.66%
ROE 7.4%
ROIC N/A
ROA(3y)0.81%
ROA(5y)0.79%
ROE(3y)8.89%
ROE(5y)8.81%
ROIC(3y)N/A
ROIC(5y)N/A
BAC Yearly ROA, ROE, ROICBAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of BAC (22.28%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BAC has declined.
The Operating Margin and Gross Margin are not available for BAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 22.28%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-9.96%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
BAC Yearly Profit, Operating, Gross MarginsBAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

BAC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BAC has less shares outstanding
The number of shares outstanding for BAC has been reduced compared to 5 years ago.
The debt/assets ratio for BAC is higher compared to a year ago.
BAC Yearly Shares OutstandingBAC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B
BAC Yearly Total Debt VS Total AssetsBAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1T 2T 3T

2.2 Solvency

A Debt/Equity ratio of 2.46 is on the high side and indicates that BAC has dependencies on debt financing.
BAC has a worse Debt to Equity ratio (2.46) than 93.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.46
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC11.6%
BAC Yearly LT Debt VS Equity VS FCFBAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BAC Yearly Current Assets VS Current LiabilitesBAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B 500B

4

3. Growth

3.1 Past

The earnings per share for BAC have decreased by -3.80% in the last year.
The Earnings Per Share has been growing slightly by 3.50% on average over the past years.
The Revenue has been growing slightly by 3.35% in the past year.
Measured over the past years, BAC shows a small growth in Revenue. The Revenue has been growing by 2.23% on average per year.
EPS 1Y (TTM)-3.8%
EPS 3Y-0.4%
EPS 5Y3.5%
EPS Q2Q%17.14%
Revenue 1Y (TTM)3.35%
Revenue growth 3Y4.57%
Revenue growth 5Y2.23%
Sales Q2Q%15.37%

3.2 Future

Based on estimates for the next years, BAC will show a small growth in Earnings Per Share. The EPS will grow by 7.05% on average per year.
Based on estimates for the next years, BAC will show a small growth in Revenue. The Revenue will grow by 3.18% on average per year.
EPS Next Y13.28%
EPS Next 2Y15.85%
EPS Next 3Y14.2%
EPS Next 5Y7.05%
Revenue Next Year6.67%
Revenue Next 2Y6.43%
Revenue Next 3Y5.6%
Revenue Next 5Y3.18%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BAC Yearly Revenue VS EstimatesBAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20B 40B 60B 80B 100B
BAC Yearly EPS VS EstimatesBAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.19, which indicates a correct valuation of BAC.
BAC's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of BAC to the average of the S&P500 Index (28.20), we can say BAC is valued slightly cheaper.
A Price/Forward Earnings ratio of 12.52 indicates a correct valuation of BAC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BAC is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 94.48. BAC is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.19
Fwd PE 12.52
BAC Price Earnings VS Forward Price EarningsBAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BAC Per share dataBAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

BAC's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BAC's earnings are expected to grow with 14.20% in the coming years.
PEG (NY)1.07
PEG (5Y)4.05
EPS Next 2Y15.85%
EPS Next 3Y14.2%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.18%, BAC has a reasonable but not impressive dividend return.
BAC's Dividend Yield is slightly below the industry average, which is at 3.10.
BAC's Dividend Yield is comparable with the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 2.18%

5.2 History

On average, the dividend of BAC grows each year by 10.60%, which is quite nice.
BAC has been paying a dividend for at least 10 years, so it has a reliable track record.
BAC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.6%
Div Incr Years11
Div Non Decr Years15
BAC Yearly Dividends per shareBAC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

BAC pays out 43.12% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of BAC is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP43.12%
EPS Next 2Y15.85%
EPS Next 3Y14.2%
BAC Yearly Income VS Free CF VS DividendBAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B
BAC Dividend Payout.BAC Dividend Payout, showing the Payout Ratio.BAC Dividend Payout.PayoutRetained Earnings

BANK OF AMERICA CORP

NYSE:BAC (2/10/2025, 8:04:00 PM)

After market: 46.65 -0.02 (-0.04%)

46.67

-0.73 (-1.54%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-16 2025-01-16/bmo
Earnings (Next)N/A N/A
Inst Owners60.7%
Inst Owner Change-11.08%
Ins Owners0.13%
Ins Owner Change-0.51%
Market Cap358.09B
Analysts80
Price Target51.83 (11.06%)
Short Float %1.05%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 2.18%
Yearly Dividend1.14
Dividend Growth(5Y)10.6%
DP43.12%
Div Incr Years11
Div Non Decr Years15
Ex-Date03-07 2025-03-07 (0.26)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.82%
Min EPS beat(2)3.15%
Max EPS beat(2)4.48%
EPS beat(4)4
Avg EPS beat(4)4.46%
Min EPS beat(4)1.6%
Max EPS beat(4)8.61%
EPS beat(8)8
Avg EPS beat(8)6.75%
EPS beat(12)12
Avg EPS beat(12)6.15%
EPS beat(16)16
Avg EPS beat(16)8.21%
Revenue beat(2)1
Avg Revenue beat(2)0.03%
Min Revenue beat(2)-0.19%
Max Revenue beat(2)0.26%
Revenue beat(4)2
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-7.83%
Max Revenue beat(4)1.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.46%
Revenue beat(12)5
Avg Revenue beat(12)-0.35%
Revenue beat(16)7
Avg Revenue beat(16)-0.31%
PT rev (1m)4.29%
PT rev (3m)10.46%
EPS NQ rev (1m)-1.64%
EPS NQ rev (3m)-1.64%
EPS NY rev (1m)0.52%
EPS NY rev (3m)0.94%
Revenue NQ rev (1m)-0.04%
Revenue NQ rev (3m)-0.04%
Revenue NY rev (1m)1.46%
Revenue NY rev (3m)2.01%
Valuation
Industry RankSector Rank
PE 14.19
Fwd PE 12.52
P/S 3.64
P/FCF N/A
P/OCF N/A
P/B 1.21
P/tB 1.59
EV/EBITDA N/A
EPS(TTM)3.29
EY7.05%
EPS(NY)3.73
Fwd EY7.99%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS12.84
BVpS38.64
TBVpS29.4
PEG (NY)1.07
PEG (5Y)4.05
Profitability
Industry RankSector Rank
ROA 0.66%
ROE 7.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 22.28%
GM N/A
FCFM N/A
ROA(3y)0.81%
ROA(5y)0.79%
ROE(3y)8.89%
ROE(5y)8.81%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-9.96%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 2.46
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACC11.6%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.8%
EPS 3Y-0.4%
EPS 5Y3.5%
EPS Q2Q%17.14%
EPS Next Y13.28%
EPS Next 2Y15.85%
EPS Next 3Y14.2%
EPS Next 5Y7.05%
Revenue 1Y (TTM)3.35%
Revenue growth 3Y4.57%
Revenue growth 5Y2.23%
Sales Q2Q%15.37%
Revenue Next Year6.67%
Revenue Next 2Y6.43%
Revenue Next 3Y5.6%
Revenue Next 5Y3.18%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-104.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.61%
OCF growth 3YN/A
OCF growth 5YN/A